CDC Commits To P.E. Foursome In Latin America

Feb 26 2008 | 12:10pm ET

CDC Group, the US$4 billion U.K. government-backed emerging markets fund of private equity funds, has made new commitments totaling US$180 million to four private equity funds in Latin America.

CDC has made allocations to Actis Latin American Private Equity Fund III, a Brazil-focused fund on mid-market buyouts; Aureos Latin America Fund, a pan-regional fund; Patria’s Brazilian Private Equity Fund III, which invests in Brazilian middle-market companies; and Advent Latin American Private Equity Fund IV, which invests in Mexico and Brazil.

The investments bring CDC’s overall investment in Latin America to US$976 million.

“Throughout Latin America there remains a shortage of funding for small and mid-size private businesses and a widespread need for private equity,” said Sven Söderblom, CDC’s portfolio director for Latin America. “In particular, Brazil, which is the largest economy in Latin America, currently offers great opportunities for private equity, with robust growth projections, a fast growing middle class and fragmented industry sectors.”
 
CDC currently has US $2.2 billion invested with over 30 fund managers in over 80 funds.


In Depth

Israeli Hedge Fund Harnesses Big Data

Jul 28 2014 | 8:10am ET

Apica Green is a multi-million dollar Israeli hedge fund that is based in Tel Aviv...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

Compelling Opportunities In The Alternatives Space

Jul 29 2014 | 9:33am ET

In an environment where many asset classes seem expensive by historical standards...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note